0001209191-20-003457.txt : 20200115
0001209191-20-003457.hdr.sgml : 20200115
20200115160848
ACCESSION NUMBER: 0001209191-20-003457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200113
FILED AS OF DATE: 20200115
DATE AS OF CHANGE: 20200115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20528393
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-13
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CL&AO
Common Stock
2020-01-13
4
M
0
2125
90.29
A
37128
D
Common Stock
2020-01-13
4
S
0
300
225.27
D
36828
D
Common Stock
2020-01-13
4
S
0
1225
226.42
D
35603
D
Common Stock
2020-01-13
4
S
0
300
227.56
D
35303
D
Common Stock
2020-01-13
4
S
0
300
228.99
D
35003
D
Stock Option (Right to Buy)
90.29
2020-01-13
4
M
0
2125
0.00
D
2026-07-11
Common Stock
2125
4250
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $225.27 (range $224.75 to $225.57).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $226.42 (range $226.06 to $227.01).
Open market sales reported on this line occurred at a weighted average price of $227.56 (range $227.53 to $227.62).
Open market sales reported on this line occurred at a weighted average price of $228.99 (range $228.79 to $229.27).
The option vests in 16 quarterly installments from 07/12/2016.
/s/ Omar White, Attorney-in-Fact
2020-01-15